Berger, C., Langsetmo, L., Joseph, L., Hanley, D. A., Davison, K. S., Josse, R., Kreiger, N., Tenenhouse, A., Goltzman, D., Poliquin, S., Godmaire, S., Joyce, C., Kovacs, C., Sheppard, E., Kirkland, S., Kaiser, S., Stanfield, B., Brown, J. P., Bessette, L., ... Vigna, Y. (2008). Change in bone mineral density as a function of age in women and men and association with the use of antiresorptive agents. CMAJ, 178(13), 1660-1668. https://doi.org/10.1503/cmaj.071416
Berger, C, Langsetmo, L, Joseph, L, Hanley, DA, Davison, KS, Josse, R, Kreiger, N, Tenenhouse, A, Goltzman, D, Poliquin, S, Godmaire, S, Joyce, C, Kovacs, C, Sheppard, E, Kirkland, S, Kaiser, S, Stanfield, B, Brown, JP, Bessette, L, Gendreau, M, Anastassiades, T, Towheed, T, Matthews, B, Josse, B, Jamal, S, Murray, T, Gardner-Bray, B, Adachi, JD, Papaioannou, A, Pickard, L, Olszynski, WP, Thingvold, J, Allan, J, Prior, JC & Vigna, Y 2008, 'Change in bone mineral density as a function of age in women and men and association with the use of antiresorptive agents', CMAJ, vol. 178, no. 13, pp. 1660-1668. https://doi.org/10.1503/cmaj.071416
@article{d8ca4d92cc2744ad90aad1594a788fc9,
title = "Change in bone mineral density as a function of age in women and men and association with the use of antiresorptive agents",
abstract = "Background: Measurement of bone mineral density is the most common method of diagnosing and assessing osteoporosis. We sought to estimate the average rate of change in bone mineral density as a function of age among Canadians aged 25-85, stratified by sex and use of antiresorptive agents. Methods: We examined a longitudinal cohort of 9423 participants. We measured the bone mineral density in the lumbar spine, total hip and femoral neck at baseline in 1995-1997, and at 3-year (participants aged 40-60 years only) and 5-year follow-up visits. We used the measurements to compute individual rates of change. Results: Bone loss in all 3 skeletal sites began among women at age 40-44. Bone loss was particularly rapid in the total hip and was greatest among women aged 50-54 who were transitioning from premenopause to postmenopause, with a change from baseline of -6.8% (95% confidence interval [CI] -7.5% to -4.9%) over 5 years. The rate of decline, particularly in the total hip, increased again among women older than 70 years. Bone loss in all 3 skeletal sites began at an earlier age (25-39) among men than among women. The rate of decline of bone density in the total hip was nearly constant among men 35 and older and then increased among men older than 65. Use of antiresorptive agents was associated with attenuated bone loss in both sexes among participants aged 50-79. Interpretation: The period of accelerated loss of bone mineral density in the hip bones occurring among women and men older than 65 may be an important contributor to the increased incidence of hip fracture among patients in that age group. The extent of bone loss that we observed in both sexes indicates that, in the absence of additional risk factors or therapy, repeat testing of bone mineral density to diagnose osteoporosis could be delayed to every 5 years.",
author = "Claudie Berger and Lisa Langsetmo and Lawrence Joseph and Hanley, {David A.} and Davison, {K. Shawn} and Robert Josse and Nancy Kreiger and Alan Tenenhouse and David Goltzman and Suzette Poliquin and Suzanne Godmaire and Carol Joyce and Christopher Kovacs and Emma Sheppard and Susan Kirkland and Stephanie Kaiser and Barbara Stanfield and Brown, {Jacques P.} and Louis Bessette and Marc Gendreau and Tassos Anastassiades and Tanveer Towheed and Barbara Matthews and Bob Josse and Sophie Jamal and Tim Murray and Barbara Gardner-Bray and Adachi, {Jonathan D.} and Alexandra Papaioannou and Laura Pickard and Olszynski, {Wojciech P.} and Jola Thingvold and Jane Allan and Prior, {Jerilynn C.} and Yvette Vigna",
year = "2008",
month = jun,
day = "17",
doi = "10.1503/cmaj.071416",
language = "English",
volume = "178",
pages = "1660--1668",
journal = "CMAJ",
issn = "0820-3946",
publisher = "Canadian Medical Association",
number = "13",
}
TY - JOUR
T1 - Change in bone mineral density as a function of age in women and men and association with the use of antiresorptive agents
AU - Berger, Claudie
AU - Langsetmo, Lisa
AU - Joseph, Lawrence
AU - Hanley, David A.
AU - Davison, K. Shawn
AU - Josse, Robert
AU - Kreiger, Nancy
AU - Tenenhouse, Alan
AU - Goltzman, David
AU - Poliquin, Suzette
AU - Godmaire, Suzanne
AU - Joyce, Carol
AU - Kovacs, Christopher
AU - Sheppard, Emma
AU - Kirkland, Susan
AU - Kaiser, Stephanie
AU - Stanfield, Barbara
AU - Brown, Jacques P.
AU - Bessette, Louis
AU - Gendreau, Marc
AU - Anastassiades, Tassos
AU - Towheed, Tanveer
AU - Matthews, Barbara
AU - Josse, Bob
AU - Jamal, Sophie
AU - Murray, Tim
AU - Gardner-Bray, Barbara
AU - Adachi, Jonathan D.
AU - Papaioannou, Alexandra
AU - Pickard, Laura
AU - Olszynski, Wojciech P.
AU - Thingvold, Jola
AU - Allan, Jane
AU - Prior, Jerilynn C.
AU - Vigna, Yvette
PY - 2008/6/17
Y1 - 2008/6/17
N2 - Background: Measurement of bone mineral density is the most common method of diagnosing and assessing osteoporosis. We sought to estimate the average rate of change in bone mineral density as a function of age among Canadians aged 25-85, stratified by sex and use of antiresorptive agents. Methods: We examined a longitudinal cohort of 9423 participants. We measured the bone mineral density in the lumbar spine, total hip and femoral neck at baseline in 1995-1997, and at 3-year (participants aged 40-60 years only) and 5-year follow-up visits. We used the measurements to compute individual rates of change. Results: Bone loss in all 3 skeletal sites began among women at age 40-44. Bone loss was particularly rapid in the total hip and was greatest among women aged 50-54 who were transitioning from premenopause to postmenopause, with a change from baseline of -6.8% (95% confidence interval [CI] -7.5% to -4.9%) over 5 years. The rate of decline, particularly in the total hip, increased again among women older than 70 years. Bone loss in all 3 skeletal sites began at an earlier age (25-39) among men than among women. The rate of decline of bone density in the total hip was nearly constant among men 35 and older and then increased among men older than 65. Use of antiresorptive agents was associated with attenuated bone loss in both sexes among participants aged 50-79. Interpretation: The period of accelerated loss of bone mineral density in the hip bones occurring among women and men older than 65 may be an important contributor to the increased incidence of hip fracture among patients in that age group. The extent of bone loss that we observed in both sexes indicates that, in the absence of additional risk factors or therapy, repeat testing of bone mineral density to diagnose osteoporosis could be delayed to every 5 years.
AB - Background: Measurement of bone mineral density is the most common method of diagnosing and assessing osteoporosis. We sought to estimate the average rate of change in bone mineral density as a function of age among Canadians aged 25-85, stratified by sex and use of antiresorptive agents. Methods: We examined a longitudinal cohort of 9423 participants. We measured the bone mineral density in the lumbar spine, total hip and femoral neck at baseline in 1995-1997, and at 3-year (participants aged 40-60 years only) and 5-year follow-up visits. We used the measurements to compute individual rates of change. Results: Bone loss in all 3 skeletal sites began among women at age 40-44. Bone loss was particularly rapid in the total hip and was greatest among women aged 50-54 who were transitioning from premenopause to postmenopause, with a change from baseline of -6.8% (95% confidence interval [CI] -7.5% to -4.9%) over 5 years. The rate of decline, particularly in the total hip, increased again among women older than 70 years. Bone loss in all 3 skeletal sites began at an earlier age (25-39) among men than among women. The rate of decline of bone density in the total hip was nearly constant among men 35 and older and then increased among men older than 65. Use of antiresorptive agents was associated with attenuated bone loss in both sexes among participants aged 50-79. Interpretation: The period of accelerated loss of bone mineral density in the hip bones occurring among women and men older than 65 may be an important contributor to the increased incidence of hip fracture among patients in that age group. The extent of bone loss that we observed in both sexes indicates that, in the absence of additional risk factors or therapy, repeat testing of bone mineral density to diagnose osteoporosis could be delayed to every 5 years.
UR - http://www.scopus.com/inward/record.url?scp=46049083826&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=46049083826&partnerID=8YFLogxK
U2 - 10.1503/cmaj.071416
DO - 10.1503/cmaj.071416
M3 - Article
C2 - 18559803
AN - SCOPUS:46049083826
SN - 0820-3946
VL - 178
SP - 1660
EP - 1668
JO - CMAJ
JF - CMAJ
IS - 13
ER -